Tamoxifen Induces Radioresistance through NRF2-Mediated Metabolic Reprogramming in Breast Cancer

0
164
Wild-type ERα-positive MCF7 and ERα-negative MDA-MB-231 breast cancer cells and their tamoxifen-resistant counterparts were analyzed for cellular metabolism using the Seahorse metabolic analyzer.
[Cancer & Metabolism]
Full Article